Stocktoria
PLUS THERAPEUTICS, INC. PSTV
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2000-08-09
PLUS THERAPEUTICS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -293.5% | -252.3% | -271.1% | — | — |
| Net margin | -429.4% | -222.8% | -271.0% | — | — |
| FCF margin | -399.8% | -183.7% | -264.8% | — | — |
| Return on assets | -137.1% | -195.7% | -116.9% | -84.9% | -61.0% |
| Return on equity | -560.2% | 145.0% | 987.8% | -314.6% | -123.7% |
| Debt / equity | — | — | — | 0.59× | 0.46× |
| Current ratio | 1.23 | 0.34 | 0.92 | 1.84 | 3.36 |
| Revenue growth | -10.5% | 18.5% | — | — | — |
Source: SEC EDGAR filings · CIK 0001095981 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.